NCT00106561View on ClinicalTrials.gov

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

September 30, 2004

Conditions
Kidney DiseaseDiabetic NephropathyGlomerulonephritisProteinuria
Interventions
DRUG

Spironolactone

DRUG

Irbesartan

Trial Locations (1)

3050

Department of Nephrology, The Royal Melbourne Hospital, Melbourne

Sponsors

Lead Sponsor

Melbourne Health
All Listed Sponsors
lead

Melbourne Health

OTHER